首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1171589

微電信業者的全球市場預測(2022年～2027年)

Global Microcarrier Market - Forecasts from 2022 to 2027

出版日期: 2022年11月30日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球微電信業者的市場規模在2020年估算為7億4,375萬美金，在預測期間內預計將以11.55％的年複合成長率增長，到2027年達到15億9,806萬6,000美元。市場成長的主要因素有生物製劑和生物仿製藥行業的快速增長。然而，細胞生物製劑和基於細胞的療法的高成本可能會阻礙預測期內的市場增長。

本報告提供全球微電信業者市場相關調查，提供市場規模和預測，COVID-19影響，市場促進因素及課題，市場趨勢，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

Microcarriers are microscopic beads or spheres used to increase the surface area in tissue culture for the attachment and yield of anchorage-dependent cells and act as a support matrix, which allows the growth of adherent cells in bioreactors. Microcarriers are extensively used in the large-scale commercial production of biologics and vaccines to grow virus-generating or protein-producing adherent cell populations. The growth in the microcarriers market may be attributed to the rapid growth in the biologics and biosimilar industries. Rising demand for cell-based vaccines along with technological advancements will positively impact the market for microcarriers. However, the high cost of cell biologics and cell-based therapies might hamper the growth of the market during the given forecast period. Growth limitations of high-density microcarrier cultures will also restrain the growth of the microcarrier market during the anticipated period. Further, the microcarrier market is segmented into product, application, end-user, and geography.

The Microcarriers market will grow due to the rising demand for cell-based vaccines.

Due to the growing number of new virus outbreaks such as influenza, monkeypox, Ebola, and COVID-19 among others, the demand for vaccines is increasing globally, consequently increasing the demand for microcarriers in the market and supporting the growth of the microcarrier market during the forecast period. For instance, the World Health Organization's Disease Outbreak News (DONs), which provided confirmed acute public health events of potential events of concern reported an Ebola virus outbreak in the Democratic Republic of the Congo in September 2022. The Ministry of Health of the Democratic Republic of the Congo declared the outbreak following the confirmed laboratory test via RT-PCR in a fatal case in Beni Health Zone, North Kivu Province.

During the same period, Uganda also witnessed a confirmed 18 cases as of 25th September 2022 Ebola virus which were caused by Sudan Virus. Such increasing cases of infectious diseases and the growing risk of pandemics are the prime factors driving the demand for vaccines worldwide. Moreover, in June 2022, just after a few months of recovery from the disruptions of the COVID-19 pandemic, the outbreak of monkeypox in different countries alarmed the vaccine developer companies to take measures to control the spread of the new virus. Further, many organizations are putting efforts to develop vaccines for the rising disease. For instance, the Centers for Disease Control and Prevention (CDC) mentions in its Vaccine considerations summary updated in September 2022, that the JYNNEOS vaccine is approved for the prevention of monkeypox and smallpox diseases. Further, the ACAM2000 Vaccines has been approved for immunization against smallpox which is made available for use against monkeypox under Expanded Access Investigational New Drug protocol, mentions the CDC.

The microcarrier market is expected to be dominated by the North American region, which is expected to hold a significant share of the Microcarrier market. The rising research and development activities, gene therapies, and biologics, coupled with technological advancement and investment in cell-based research in the countries like the US. Additionally, the prevalence of established pharmaceutical companies, who continually work to expand their geographic reach and promote the widespread marketing of their vaccines, is anticipated to spur market expansion in this region. Moreover, this region will grow due to the increased need for immunizations during pandemics. due to the rise in the prevalence of infectious and cancerous illnesses. On the other hand, Europe holds the second largest share of the microcarrier market during the anticipated period owing to the increasing number of leading firms in the market and growing usage of technical innovations. It is anticipated that increased R&D utilization will enhance product development and market demand in this region.

Product offering

Thermo Fisher Scientific offers the HarvestainerTM Microcarrier Separation system which is an ideal solution for the separation of microcarrier beads during adherent cell culture production. It is an ideal system for smaller-scale as well as larger-scale applications for in-line microcarrier separation. In comparison to conventional procedures, the system helps to boost product yields while lowering the need for clean-in-place, steam-in-place, and water for injection.
Corning incorporated offers Corning® Microcarriers for Bioprocess scale-up that are designed to simplify the scale-up processes. The microcarriers are provided in closed systems packaging, are sterile, and are prepared for use with bioreactors. The microcarriers are additionally surface-treated to improve cell adhesion and increase cell production and survival.

COVID-19 Impact

The pandemic had a positive impact on the microcarrier market. The virus spread rapidly through transmission. Pharmaceutical companies stepped forward to develop vaccines to combat the rising risk of COVID-19. Many organizations pushed their efforts of research and development to develop vaccines and drugs against the coronavirus. Furthermore, government and world organizations provided funding to increase the research on vaccines for the deadly coronavirus, which further increased the demand for cell culture products, including microcarrier products during the pandemic.

Market Segmentation:

By Product type

Equipment

Consumables

Reagents

Microcarrier Beads

Others

By Application

Biopharmaceutical Production

Cell and gene therapy

Others

By End-Users

Pharmaceuticals & Biotechnology Companies

Research Institutes

Contract Research Organizations

By Geography

North America

USA
Canada
Mexico

South America

Brazil
Argentina
Others

Europe

United Kingdom
Germany
France
Spain
Others

Middle East and Africa

Saudi Arabia
UAE
Israel
Others

Asia Pacific

China
India
Japan
South Korea
Indonesia
Others

1. INTRODUCTION

1.1. Market Overview
1.2. COVID-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. MICROCARRIERS MARKET, BY PRODUCT TYPE

5.1. Introduction
5.2. Equipment
5.3. Consumables
- 5.3.1. Reagents
- 5.3.2. Microcarrier Beads
- 5.3.3. Others

6. MICROCARRIERS MARKET, BY APPLICATION

6.1. Introduction
6.2. Biopharmaceutical Production
6.3. Cell and gene therapy
6.4. Others

7. MICROCARRIERS MARKET, BY END-USER

7.1. Introduction
7.2. Pharmaceuticals & Biotechnology Companies
7.3. Research Institutes
7.4. Contract Research Organizations

8. MICROCARRIERS MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Others